The potential biological mechanism of IL-17 mediated tumor immunity may be that IL-17 can absorb Th1-related chemokines, such as CXC19 and CXC110, which can promote the migration of effector T cells to tumor sites and increase the number of CD8+ T cells (41). This evidence concerns the gene CD8A and neoplasm.